Literature DB >> 21969236

Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer.

Gallya Gannot, Annely M Richardson, Jaime Rodriguez-Canales, Peter A Pinto, Maria J Merino, Rodrigo F Chuaqui, John W Gillespie, Michael R Emmert-Buck.   

Abstract

The tumor microenvironment is comprised of multiple cell types arranged in a three-dimensional structure. Interactions amongst the various cell components play an important role in neoplasia, including the inflammatory reaction that occurs as part of the host response. In this study, the regional lymphocyte subpopulations and cytokine profiles associated with prostate cancer were examined using a quantitative imaging approach and expression microarray analysis. Lymphocytes were measured in four different epithelial phenotypes in prostate cancer specimens: carcinoma; prostatic intraepithelial neoplasia (PIN); benign prostate hyperplasia (BPH); and normal epithelium. The data indicate that CD8 positive, cytotoxic T lymphocytes are significantly decreased in regions adjacent to hyperplasia and carcinoma as compared to normal epithelium and PIN. In contrast the relative number of CD4 positive and CD20 positive lymphocytes did not change markedly. Parallel mRNA expression array analysis of the normal and tumor microenvironments identified a distinct cytokine profile in cancer, with 24 dysregulated genes in tumor epithelium and nine altered in tumor-associated stroma. Overall, these data indicate that the spatial distribution of CD8 positive, cytotoxic T lymphocytes is dysregulated in human prostate glands that contain cancer, and cytokine profiles are altered at the mRNA level.

Entities:  

Year:  2010        PMID: 21969236      PMCID: PMC3180108     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  19 in total

1.  T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.

Authors:  S Iyengar; D H Schwartz; J E Hildreth
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Evaluation of non-formalin tissue fixation for molecular profiling studies.

Authors:  John W Gillespie; Carolyn J M Best; Verena E Bichsel; Kristina A Cole; Susan F Greenhut; Stephen M Hewitt; Mamoun Ahram; Yvonne B Gathright; Maria J Merino; Robert L Strausberg; Jonathan I Epstein; Stanley R Hamilton; Gallya Gannot; Galina V Baibakova; Valerie S Calvert; Michael J Flaig; Rodrigo F Chuaqui; Judi C Herring; John Pfeifer; Emmanuel F Petricoin; W Marston Linehan; Paul H Duray; G Steven Bova; Michael R Emmert-Buck
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

3.  Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy.

Authors:  Vesa Kärjä; Sirpa Aaltomaa; Pertti Lipponen; Taina Isotalo; Martti Talja; Risto Mokka
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

Review 4.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation.

Authors:  B Elenbaas; R A Weinberg
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

5.  MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment.

Authors:  Navreet K Nanda; Lynn Birch; Norman M Greenberg; Gail S Prins
Journal:  Prostate       Date:  2006-09-01       Impact factor: 4.104

Review 6.  Does the immune system see tumors as foreign or self?

Authors:  Drew Pardoll
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Global expression analysis of prostate cancer-associated stroma and epithelia.

Authors:  Annely M Richardson; Karen Woodson; Yonghong Wang; Jaime Rodriguez-Canales; Heidi S Erickson; Michael A Tangrea; Kristian Novakovic; Sergio Gonzalez; Alfredo Velasco; Ernest S Kawasaki; Michael R Emmert-Buck; Rodrigo F Chuaqui; Audrey Player
Journal:  Diagn Mol Pathol       Date:  2007-12

Review 9.  Cell death mechanisms induced by cytotoxic lymphocytes.

Authors:  L Chávez-Galán; M C Arenas-Del Angel; E Zenteno; R Chávez; R Lascurain
Journal:  Cell Mol Immunol       Date:  2009-02       Impact factor: 11.530

10.  Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma.

Authors:  G Gannot; I Gannot; H Vered; A Buchner; Y Keisari
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

View more
  5 in total

1.  Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients.

Authors:  Hai-Bo Chu; Ting-Guo Zhang; Jian-Hua Zhao; Feng-Guo Jian; Yong-Bo Xu; Tao Wang; Min Wang; Jin-Yuan Tang; Hong-Jie Sun; Kun Li; Wen-Jun Guo; Xiao-Ji Zhu
Journal:  BMC Immunol       Date:  2014-10-08       Impact factor: 3.615

2.  The Relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure.

Authors:  Charnita Zeigler-Johnson; Knashawn H Morales; Priti Lal; Michael Feldman
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 3.  Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.

Authors:  Jennifer L Kalina; David S Neilson; Alexandra P Comber; Jennifer M Rauw; Abraham S Alexander; Joanna Vergidis; Julian J Lum
Journal:  Cancers (Basel)       Date:  2017-01-27       Impact factor: 6.639

4.  Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.

Authors:  Stephanie O Dudzinski; Brent D Cameron; Jian Wang; Jeffrey C Rathmell; Todd D Giorgio; Austin N Kirschner
Journal:  J Immunother Cancer       Date:  2019-08-14       Impact factor: 13.751

5.  Tumor infiltrating B-cells are increased in prostate cancer tissue.

Authors:  Jason R Woo; Michael A Liss; Michelle T Muldong; Kerrin Palazzi; Amy Strasner; Massimo Ammirante; Nissi Varki; Ahmed Shabaik; Stephen Howell; Christopher J Kane; Michael Karin; Christina A M Jamieson
Journal:  J Transl Med       Date:  2014-01-30       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.